OAC Statement on GLP-1 Medications as a Long-Term Treatment Strategy for Obesity
in 2025 News Releases, News Releases on December 1, 2025

Tampa, FL., December 1, 2025 – Statement from Obesity Action Coalition (OAC) President and CEO Joe Nadglowski: “The World Health Organization’s new recommendation for GLP-1 medications as part of a long-term treatment strategy for obesity is a significant milestone in recognizing obesity as a chronic, treatable disease. These medications, which can help reduce weight and
Read Article